Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index; 166 of the 371 sources its claims cite were checked for support.

Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes

Open access
ten Brink, Tim, Damanik, Febriyani, Rotmans, Joris I., Moroni, Lorenzo · 2024 · Advanced Healthcare Materials

Abstract

Biomaterials are defined as "engineered materials" and include a range of natural and synthetic products, designed for their introduction into and interaction with living tissues. Biomaterials are considered prominent tools in regenerative medicine that support the restoration of tissue defects and retain physiologic functionality. Although commonly used in the medical field, these constructs are inherently foreign toward the host and induce an immune response at the material-tissue interface, defined as the foreign body response (FBR). A strong connection between the foreign body response and tissue regeneration is suggested, in which an appropriate amount of immune response and macrophage polarization is necessary to trigger autologous tissue formation. Recent developments in this field have led to the characterization of immunomodulatory traits that optimizes bioactivity, the integration of biomaterials and determines the fate of tissue regeneration. This review addresses a variety of aspects that are involved in steering the inflammatory response, including immune cell interactions, physical characteristics, biochemical cues, and metabolomics. Harnessing the advancing knowledge of the FBR allows for the optimization of biomaterial-based implants, aiming to prevent damage of the implant, improve natural regeneration, and provide the tools for an efficient and successful in vivo implantation.

Overview

CoChat Summary

## TL;DR

This is a review of how biomaterial properties and the immune microenvironment shape the foreign body response (FBR) and tissue regeneration. It argues that tuning physical, biochemical, and metabolic cues can shift inflammation toward a regenerative phenotype and improve implant integration.

## Key findings

  • The review states that biomaterial implantation always triggers an immune response and that improper integration can lead to chronic inflammation, fibrous capsule formation, isolation, or rejection of the implant; it also says no material currently exists that is biologically accepted and free of adverse effects.
  • Size, geometry, topography, stiffness, porosity, and wettability all influence immune behavior: for example, smaller PLGA 5 µm microspheres showed cellular and macrophage influx, phagocytosis, and collagen deposition, while 29.8 µm spheres induced only occasional FBGCs; spheres ≤0.5 mm induced severe FBR whereas 1.5 mm spheres scarcely did.
  • Several cited studies suggest surface and scaffold design can favor anti-inflammatory polarization: rough-hydrophilic titanium surfaces increased Th2/Treg-related genes after 3 days, 400–500 nm grooves on titanium gave the highest IL-10 and Arg1-positive cells, and 40–60 µm pore PCL scaffolds promoted M2 markers such as CD163/CD206 and IL-10.
  • Biochemical cues can be leveraged to steer repair: in one example, IL-4-releasing biomaterial conduits led to a significant increase in M2 macrophages and axon regeneration 20 times greater than IFN-γ-releasing tubes; in another, PDGF-ββ/FGF-2 supported macrophage infiltration before robust vessel formation and pericyte recruitment.

## Methods

  • Narrative review of recent literature on biomaterials and immune responses at the cell–biomaterial interface, organized around implantation/FBR, inflammatory cell types, physical properties, biochemical cues, and metabolomics.
  • Synthesizes evidence from in vitro studies, in vivo animal models (including mice, rats, rabbits, sheep, pigs, and primates), and coculture systems across many biomaterial classes.
  • No single new experimental dataset or primary statistical analysis is reported in the paper itself; the paper compiles and interprets findings from prior studies.

## Limitations

  • The paper explicitly notes several places where the evidence remains incomplete or mixed: for example, “further investigation” is needed for different implant architectures, the exact optimal roughness was not determined in some studies, and long-term stability should be confirmed for some sequential growth-factor releases.
  • The text makes evident that much of the evidence is study-specific and not directly comparable across materials, shapes, cell types, and implantation sites; this limits generalization of any single “best” design choice (evident from the heterogeneous examples summarized).
  • The paper explicitly states that some approaches were only tested in vitro and need in vivo validation, such as GAG-coated biomaterials; it also notes several cases where in vitro and in vivo results did not match.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/adhm.202301939

Cites

284 of 284 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A progression chart of the foreign body response induced by a biomaterial, displaying the major cell types and effects over time. 1) Upon implantation, blood–matrix interactions recruit platelets in order to initiate site sterilization and wound closure. 2) Neutrophils and platelets excrete products to form a provisional matrix, which aids in further recruitment of inflammatory cells (A). 3) A collection of inflammatory cells, including monocytes, Th cells, and fibroblasts migrate to the wound site and initiate the inflammatory response to phagocytose pathogens and remodel the microenvironment (B). Over time, monocytes differentiate to macrophages and take on either a proinflammatory (M1) or anti‐inflammatory (M2) phenotype. Chronic inflammation of the wound site is often caused by the foreign nature of the biomaterial resulting in further macrophage polarization and recruitment of fibroblasts (C). 4) Persisting inflammation leads to the fusion of macrophages, forming a foreign body giant cell. FBGCs attempt to engulf the biomaterial in order to isolate the implant from the environment through frustrated phagocytosis (D). The combination of FBGCs and continuous collagen output by fibroblasts forms a fibrous foreign body capsule around the implant, indicating a chronically inflamed state.
Figure 1 A progression chart of the foreign body response induced by a biomaterial, displaying the major cell types and effects over time. 1) Upon implantation, blood–matrix interactions recruit platelets in order to initiate site sterilization and wound closure. 2) Neutrophils and platelets excrete products to form a provisional matrix, which aids in further recruitment of inflammatory cells (A). 3) A collection of inflammatory cells, including monocytes, Th cells, and fibroblasts migrate to the wound site and initiate the inflammatory response to phagocytose pathogens and remodel the microenvironment (B). Over time, monocytes differentiate to macrophages and take on either a proinflammatory (M1) or anti‐inflammatory (M2) phenotype. Chronic inflammation of the wound site is often caused by the foreign nature of the biomaterial resulting in further macrophage polarization and recruitment of fibroblasts (C). 4) Persisting inflammation leads to the fusion of macrophages, forming a foreign body giant cell. FBGCs attempt to engulf the biomaterial in order to isolate the implant from the environment through frustrated phagocytosis (D). The combination of FBGCs and continuous collagen output by fibroblasts forms a fibrous foreign body capsule around the implant, indicating a chronically inflamed state.CC BY-NC · PubMed Central
Figure 2 The macrophage phenotype spectrum is directly related to the stimulation of either inflammation (orange) or regeneration (blue) within the implant site. A combination of biochemical compounds and adaptive cell types affect monocyte behavior and the subsequent differentiation to macrophages. The differentiation to varying polarization states, either proinflammatory (M1) or anti‐inflammatory (M2), is defined by a unique mix of cytokines and chemokines present in the microenvironment. Additionally, the physical traits of the implant are able to steer polarized macrophages toward expressing inflammatory or regenerative effects.
Figure 2 The macrophage phenotype spectrum is directly related to the stimulation of either inflammation (orange) or regeneration (blue) within the implant site. A combination of biochemical compounds and adaptive cell types affect monocyte behavior and the subsequent differentiation to macrophages. The differentiation to varying polarization states, either proinflammatory (M1) or anti‐inflammatory (M2), is defined by a unique mix of cytokines and chemokines present in the microenvironment. Additionally, the physical traits of the implant are able to steer polarized macrophages toward expressing inflammatory or regenerative effects.CC BY-NC · PubMed Central
Figure 3 An overview of the crosstalk network between key cell types and inflammatory responses of the FBR. Each feature is categorized according to either inflammatory (orange) or regenerative (blue) effects it exerts on the progression of the FBR. Cellular interaction occurs through either cytokine crosstalk or direct differentiation into the directed cell type.
Figure 3 An overview of the crosstalk network between key cell types and inflammatory responses of the FBR. Each feature is categorized according to either inflammatory (orange) or regenerative (blue) effects it exerts on the progression of the FBR. Cellular interaction occurs through either cytokine crosstalk or direct differentiation into the directed cell type.CC BY-NC · PubMed Central
Figure 4 A qualitative analysis on the effect of physical biomaterial properties on the inflammatory response. Upon implantation, varying features can display a multitude of positive (↑) or negative (↓) effects on inflammatory cell types and the FBR progression. Preferred anti‐inflammatory effects are usually defined by an optimal range. A) Surface roughness is defined in µm where a roughness between 0.2 and 20 µm results in macrophage elongation and M2 polarization. Optimal polarization occurred between 0.4 and 0.5 µm. Generally, rougher surfaces are always more effective over smooth material surfaces. B) Material stiffness is expressed in kPa and concerns both the flexibility and resistance to deformation. A lower stiffness (<88 kPa) causes increased cell migration and promotes an overall anti‐inflammatory environment whilst higher stiffnesses (>300 kPa) impairs phagocytosis and stimulates inflammation. C) Porosity measures the empty space between a material that allows for cellular integration and migration. Pore ranges between 5 and 60 µm have been found to support an anti‐inflammatory environment, where pore ranges between 30 and 60 µm stimulate angiogenesis, macrophage elongation, and M2 polarization. Of note is that different cell types may prefer different pore sizes. Extremely small (<0.1 µm) or large (>160 µm) are generally unfavorable since this may stimulate fibrosis and FBC formation. Nanoporous materials could also exert positive effects on the FBR by modulating the fundamental properties of the material. D) Wettability is defined by the level of hydrophilicity of a material. Increasingly hydrophilic materials create a more anti‐inflammatory environment through providing enhanced protein absorption, cell motility, and M2 polarization. E) Crystallinity indicates the structural arrangement of atoms in a material and becomes increasingly important in stiffer components (e.g., bone tissue). Amorphous materials supported the growth and proliferation of stem cells like osteoblasts, whilst crystalline materials resulted in increased fibroblast proliferation. Of note is that a higher crystallinity may negatively affect the FBR, since persistent fibroblast activity can result in chronic inflammation through increased levels of inflammatory cytokines and a buildup of fibrous matrix.
Figure 4 A qualitative analysis on the effect of physical biomaterial properties on the inflammatory response. Upon implantation, varying features can display a multitude of positive (↑) or negative (↓) effects on inflammatory cell types and the FBR progression. Preferred anti‐inflammatory effects are usually defined by an optimal range. A) Surface roughness is defined in µm where a roughness between 0.2 and 20 µm results in macrophage elongation and M2 polarization. Optimal polarization occurred between 0.4 and 0.5 µm. Generally, rougher surfaces are always more effective over smooth material surfaces. B) Material stiffness is expressed in kPa and concerns both the flexibility and resistance to deformation. A lower stiffness (<88 kPa) causes increased cell migration and promotes an overall anti‐inflammatory environment whilst higher stiffnesses (>300 kPa) impairs phagocytosis and stimulates inflammation. C) Porosity measures the empty space between a material that allows for cellular integration and migration. Pore ranges between 5 and 60 µm have been found to support an anti‐inflammatory environment, where pore ranges between 30 and 60 µm stimulate angiogenesis, macrophage elongation, and M2 polarization. Of note is that different cell types may prefer different pore sizes. Extremely small (<0.1 µm) or large (>160 µm) are generally unfavorable since this may stimulate fibrosis and FBC formation. Nanoporous materials could also exert positive effects on the FBR by modulating the fundamental properties of the material. D) Wettability is defined by the level of hydrophilicity of a material. Increasingly hydrophilic materials create a more anti‐inflammatory environment through providing enhanced protein absorption, cell motility, and M2 polarization. E) Crystallinity indicates the structural arrangement of atoms in a material and becomes increasingly important in stiffer components (e.g., bone tissue). Amorphous materials supported the growth and proliferation of stem cells like osteoblasts, whilst crystalline materials resulted in increased fibroblast proliferation. Of note is that a higher crystallinity may negatively affect the FBR, since persistent fibroblast activity can result in chronic inflammation through increased levels of inflammatory cytokines and a buildup of fibrous matrix.CC BY-NC · PubMed Central
Figure 5 A simplified overview of metabolomic products influencing the FBR. Natural metabolic products may originate from the degradation of the biomaterial implant, be excreted by cells, or are present in the ECM. These products include signaling molecules (cytokines and interleukins), fats (lipopolysaccharides), proteins or metabolic products created through the breakdown of larger substances. Within the microenvironment of the FBR, the mixture of these products bidirectionally influences the interaction between stromal and inflammatory cells and may directly contribute toward skewing the FBR toward an inflammatory or resolutory state.
Figure 5 A simplified overview of metabolomic products influencing the FBR. Natural metabolic products may originate from the degradation of the biomaterial implant, be excreted by cells, or are present in the ECM. These products include signaling molecules (cytokines and interleukins), fats (lipopolysaccharides), proteins or metabolic products created through the breakdown of larger substances. Within the microenvironment of the FBR, the mixture of these products bidirectionally influences the interaction between stromal and inflammatory cells and may directly contribute toward skewing the FBR toward an inflammatory or resolutory state.CC BY-NC · PubMed Central
Figure 6 A predictive model depicting the creation of novel biomaterials based on products derived from the metabolome. First, naturally occurring metabolites can be isolated or synthesized as basic, biocompatible building blocks. Next, these monomers are functionalized through the addition of functional groups, creating synthons with the desired properties. These synthons are polymerized to create biomaterials, after which these can be implanted in vivo. As the material degrades over time, the compounds will revert to their original, biocompatible monomers, which are then processed and excreted through the metabolome.
Figure 6 A predictive model depicting the creation of novel biomaterials based on products derived from the metabolome. First, naturally occurring metabolites can be isolated or synthesized as basic, biocompatible building blocks. Next, these monomers are functionalized through the addition of functional groups, creating synthons with the desired properties. These synthons are polymerized to create biomaterials, after which these can be implanted in vivo. As the material degrades over time, the compounds will revert to their original, biocompatible monomers, which are then processed and excreted through the metabolome.CC BY-NC · PubMed Central

Verification

Claims the paper makes

151 Valid · 11 Not valid · 180 Not checked · 47 Own results and interpretations

158 more claims · 61 with their cited sources checked

Create a free account to see all 389 claims and to verify the 28 references still open.

See all claims — free account
  • It may state two separate claims as one. 211
  • Probably not a substantial claim. 29
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 279 references

Research works printed but not linked: 13

  1. Katari R., 2014, Front Bioeng Biotechnol., 2, 57
  2. Zakrzewski J., 2014, Nat. Biotechnol., 32
  3. Henson P. M., 1980, Am. J. Pathol., 101, 494
  4. Yu T., 2015, The Role of Macrophages in the Foreign Body Response to Implanted Biomaterials. Biomaterials in Regenerative Medicine and the Immune System, 17
  5. Alberts B., 2008, Molecular Biology of the Cell. [Hauptbd.]. [Hauptbd.]
  6. Ratner B., 2012, Biomater. Sci.
  7. Vojdani A., 2006, Complement Altern. Med., 3, 309
  8. Desmoulière A., 1995, Am. J. Pathol., 146, 56
  9. Kapalczynska M., 2018, Arch. Med. Sci., 14, 910
  10. 10.1016/j.actbio.2013.10.035 · DOI · Paper page
  11. Shakibania S., 2020, Drug Dev. Ind. Pharm., 1
  12. Göktürk E., 2017, Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 21
  13. Kim Y. H., 2015, J. Biomed. Mater. Res., A

Cited by

See all 71

Metadata

Authors
ten Brink, T., Damanik, F., Rotmans, J. I., & Moroni, L.
Affiliations
  • Complex Tissue Regeneration Department MERLN Institute for Technology‐Inspired Regenerative Medicine Maastricht University Universiteitssingel 40 Maastricht 6229ER The Netherlands
  • Maastricht University (NL)
  • Leiden University Medical Center (NL)
Corresponding author
Moroni, Lorenzo
Venue
Advanced Healthcare Materials
Publisher
Wiley
Published
2024-04-05
Volume
13
Issue
17
Pages
e2301939-e2301939
ISSN
  • 2192-2640 (ISSN-L)
  • 2192-2659
OpenAlex
W4390841222
Cited by
71
References
279
Citations by year
2026: 41 · 2025: 22 · 2024: 8
FWCI
7.84
Type
journal article
Language
en
Open access
Locations
  • Advanced Healthcare Materials (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
Funders
European Research Council (637308)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Keywords
foreign body reaction, biomaterials, tissue engineering, macrophage polarization, immunomodulation, inflammation, tissue regeneration, implant integration, metabolomics, bioactivity (biomaterials), regenerative medicine
MeSH terms
Animals, Biocompatible Materials, Foreign-Body Reaction, Humans, Tissue Engineering, Regenerative Medicine, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes. https://app.cochat.ai/papers/10.1002/adhm.202301939
The paper
ten Brink, T., Damanik, F., Rotmans, J. I., & Moroni, L. (2024). Unraveling and Harnessing the Immune Response at the Cell–Biomaterial Interface for Tissue Engineering Purposes. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301939

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.